Workshop Discrete choice modelling for the quantification of health states: the case of the EQ-5D

[1]  Rudolf T Hoogenveen,et al.  Lifetime Medical Costs of Obesity: Prevention No Cure for Increasing Health Expenditure , 2008, PLoS medicine.

[2]  Dick Tibboel,et al.  Cost-effectiveness of neonatal surgery: first greeted with scepticism, now increasingly accepted , 2008, Pediatric Surgery International.

[3]  F. Rutten,et al.  Costs and prices of single dental fillings in Europe: a micro-costing study. , 2008, Health economics.

[4]  Maiwenn J Al,et al.  Costs and effects of various analgesic treatments for patients with rheumatoid arthritis and osteoarthritis in the Netherlands. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[5]  Maiwenn J. Al,et al.  The cost utility of solifenacin in the treatment of overactive bladder , 2008, International Urology and Nephrology.

[6]  Maiwenn J Al,et al.  Cost‐effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme , 2008, Cancer.

[7]  Mark Oppe,et al.  Expected value of perfect information: an empirical example of reducing decision uncertainty by conducting additional research. , 2006, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[8]  F. Rutten,et al.  Comparing methodologies for the cost estimation of hospital services , 2009, The European Journal of Health Economics.

[9]  Marinus J C Eijkemans,et al.  A detailed cost analysis of in vitro fertilization and intracytoplasmic sperm injection treatment. , 2008, Fertility and sterility.

[10]  Heinz Schneider,et al.  Uncertainty in decision-making: value of additional information in the cost-effectiveness of lifestyle intervention in overweight and obese people. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[11]  A. Culyer,et al.  Welfarism vs. extra-welfarism. , 2008, Journal of health economics.

[12]  Thomas Renaud,et al.  Cost of illness: an international comparison. Australia, Canada, France, Germany and The Netherlands. , 2008, Health policy.

[13]  Peter C Levendag,et al.  Longitudinal changes in quality of life and costs in long-term survivors of tumors of the oropharynx treated with brachytherapy or surgery. , 2005, Brachytherapy.

[14]  Maiwenn J. Al,et al.  Review of A Large Clinical Series: A Microcosting Study of Intensive Care Unit Stay in the Netherlands , 2008, Journal of intensive care medicine.

[15]  Martine Hoogendoorn,et al.  Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands , 2008, Current medical research and opinion.

[16]  T. Stijnen,et al.  Rapid identification and antimicrobial susceptibility testing reduce antibiotic use and accelerate pathogen-directed antibiotic use. , 2007, The Journal of antimicrobial chemotherapy.

[17]  W. Brouwer,et al.  Can we fix it? Yes we can! But what? A new test of procedural invariance in TTO-measurement. , 2008, Health economics.

[18]  Werner Brouwer,et al.  Give me a break! Informal caregiver attitudes towards respite care. , 2008, Health policy.

[19]  M. Pistolesi,et al.  Outcomes for COPD pharmacological trials: from lung function to biomarkers , 2008, European Respiratory Journal.

[20]  Maiwenn J Al,et al.  The cost-utility of rotavirus vaccination with Rotarix (RIX4414) in the Netherlands. , 2008, Vaccine.